Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Nov 04, 2021	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0001804220-21-000033.pdf 0001804220-21-000033.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Nov 04, 2021	S-3ASR	S-3ASR	View HTML 0001104659-21-134393.pdf 0001104659-21-134393.xls
Nov 03, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-21-000007.pdf 0001883850-21-000007.xls
Nov 03, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-21-000006.pdf 0001883850-21-000006.xls
Oct 04, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-21-000003.pdf 0001883850-21-000003.xls
Oct 04, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-21-000004.pdf 0001883850-21-000004.xls
Sep 17, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-21-000022.pdf 0001237899-21-000022.xls
Sep 16, 2021	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-21-116352.pdf 0001104659-21-116352.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Sep 15, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-21-000080.pdf 0001708138-21-000080.xls
Sep 15, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-21-000081.pdf 0001708138-21-000081.xls

Data provided by Kaleidoscope.

Investors & Media